Payer, consumer pushback expected to dampen drug spending growth
BioPharma Dive: Biotech and Pharma news | May 04, 2017
Payers' increased negotiating power, as well as consumer pushback on high-priced prescription medications, stand to dampen drug spending over the next five years, according to a new report from QuintilesIMS, a healthcare information and technology provider.